Reduction in uptake of PSA tests following decision aids: systematic review of current aids and their evaluations.

[1]  Robert M. Kaplan,et al.  Evaluation of two methods to facilitate shared decision making for men considering the prostate-specific antigen test , 2001, Journal of General Internal Medicine.

[2]  A. Flood,et al.  The importance of patient preference in the decision to screen for prostate cancer , 1996, Journal of General Internal Medicine.

[3]  Robert J Volk,et al.  Patient Education for Informed Decision Making About Prostate Cancer Screening: A Randomized Controlled Trial with 1-Year Follow-Up , 2003, The Annals of Family Medicine.

[4]  Douglas G. Altman,et al.  Systematic Reviews in Health Care: Meta-Analysis in Context: Second Edition , 2008 .

[5]  C. Hammond,et al.  A frequently used patient and physician-directed educational intervention does nothing to improve primary care of prostate conditions. , 2001, Urology.

[6]  T. Wilt,et al.  Educating men about prostate cancer screening. A randomized trial of a mailed pamphlet. , 2001, Effective clinical practice : ECP.

[7]  J. Kleijnen,et al.  The determinants of screening uptake and interventions for increasing uptake: a systematic review. , 2000, Health technology assessment.

[8]  P Burnard,et al.  The Effectiveness of One-to-one Risk-communication Interventions in Health Care , 2000, Medical decision making : an international journal of the Society for Medical Decision Making.

[9]  Lisa M. Schwartz,et al.  Are increasing 5-year survival rates evidence of success against cancer? , 2000, JAMA.

[10]  M. Schapira,et al.  The effect of an illustrated pamphlet decision-aid on the use of prostate cancer screening tests. , 2000, The Journal of family practice.

[11]  R. Volk,et al.  Decision-aids for prostate cancer screening. , 2000, The Journal of family practice.

[12]  G. Elwyn,et al.  Judging the 'weight of evidence' in systematic reviews: introducing rigour into the qualitative overview stage by assessing Signal and Noise. , 2000, Journal of evaluation in clinical practice.

[13]  D. Wood,et al.  Screening for prostate cancer. The challenge of promoting informed decision making in the absence of definitive evidence of effectiveness. , 1999, The Medical clinics of North America.

[14]  V. Entwistle,et al.  Decision aids for patients facing health treatment or screening decisions: systematic review , 1999, BMJ.

[15]  T. Hassard,et al.  Information and patient participation in screening for prostate cancer. , 1999, Patient education and counseling.

[16]  R. Volk,et al.  A randomized controlled trial of shared decision making for prostate cancer screening. , 1999, Archives of family medicine.

[17]  A G Edwards,et al.  Efficient literature searching in diffuse topics: lessons from a systematic review of research on communicating risk to patients in primary care. , 1999, Health libraries review.

[18]  G. Chodak.  Comparing treatments for localized prostate cancer--persisting uncertainty. , 1998, JAMA.

[19]  N C Stott,et al.  Signal versus noise in the evidence base for medicine: an alternative to hierarchies of evidence? , 1998, Family practice.

[20]  J. Schorling,et al.  The impact of informed consent on patient interest in prostate-specific antigen screening. , 1996, Archives of internal medicine.

[21]  F. Mosteller,et al.  How study design affects outcomes in comparisons of therapy. I: Medical. , 1989, Statistics in medicine.

[22]  T C Chalmers,et al.  Randomized versus historical controls for clinical trials. , 1982, The American journal of medicine.